Back to results
US 2017/0319568 A1Published application
Quinoline carboxamides for use in the treatment of leukemia
AssigneeActive Biotech AB
InventorsHelena ERIKSSON, Leif SVENSSON, Marie TÖRNGREN
Life of this patent
Estimating the term…
Abstract
A compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of leukemia.
Claims19
1-17. (canceled)
A method of treatment of leukemia selected from acute lymphoblastic leukemia and acute myeloid leukemia, by administering 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]-1,2-dihydroquinoline-3-carboxamide (tasquinimod) or a pharmaceutically acceptable salt thereof to a mammal in need thereof.
Dependencies are inferred from the claim text.